

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of female gonad development (GO:2000194) | 7.35936044 |
| 2 | regulation of DNA methylation (GO:0044030) | 7.06341826 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.00714213 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.00714213 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.82060389 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.82060389 |
| 7 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 6.74534737 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.56115654 |
| 9 | piRNA metabolic process (GO:0034587) | 6.22962850 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 6.13686121 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 6.13686121 |
| 12 | tryptophan catabolic process (GO:0006569) | 6.13686121 |
| 13 | glyoxylate metabolic process (GO:0046487) | 6.06460709 |
| 14 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 5.83392498 |
| 15 | retinal cone cell development (GO:0046549) | 5.79478160 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.78797257 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.71806494 |
| 18 | lysine metabolic process (GO:0006553) | 5.53893947 |
| 19 | lysine catabolic process (GO:0006554) | 5.53893947 |
| 20 | cysteine metabolic process (GO:0006534) | 5.50372581 |
| 21 | bile acid biosynthetic process (GO:0006699) | 5.43378935 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.27700973 |
| 23 | glycine transport (GO:0015816) | 5.23884344 |
| 24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.16126699 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.13299354 |
| 26 | urea cycle (GO:0000050) | 4.97873916 |
| 27 | urea metabolic process (GO:0019627) | 4.97873916 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.96166134 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.92639421 |
| 30 | cellular ketone body metabolic process (GO:0046950) | 4.90540468 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.77052191 |
| 32 | drug transmembrane transport (GO:0006855) | 4.76021251 |
| 33 | meiotic cell cycle (GO:0051321) | 4.75493751 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.74379195 |
| 35 | multicellular organism reproduction (GO:0032504) | 4.72830164 |
| 36 | amino-acid betaine metabolic process (GO:0006577) | 4.72458612 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.64508428 |
| 38 | urate metabolic process (GO:0046415) | 4.63376773 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.58529395 |
| 40 | high-density lipoprotein particle remodeling (GO:0034375) | 4.57876880 |
| 41 | bile acid metabolic process (GO:0008206) | 4.52907270 |
| 42 | regulation of acrosome reaction (GO:0060046) | 4.52393984 |
| 43 | L-amino acid import (GO:0043092) | 4.51832259 |
| 44 | regulation of meiosis I (GO:0060631) | 4.41445082 |
| 45 | drug catabolic process (GO:0042737) | 4.41132301 |
| 46 | negative regulation of fibrinolysis (GO:0051918) | 4.38491979 |
| 47 | complement activation, alternative pathway (GO:0006957) | 4.38363143 |
| 48 | short-chain fatty acid metabolic process (GO:0046459) | 4.35647764 |
| 49 | cellular amino acid catabolic process (GO:0009063) | 4.31721616 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 4.31611422 |
| 51 | cellular biogenic amine catabolic process (GO:0042402) | 4.30396730 |
| 52 | amine catabolic process (GO:0009310) | 4.30396730 |
| 53 | indolalkylamine metabolic process (GO:0006586) | 4.29275955 |
| 54 | protein carboxylation (GO:0018214) | 4.26480763 |
| 55 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.26480763 |
| 56 | regulation of protein activation cascade (GO:2000257) | 4.24984253 |
| 57 | regulation of fibrinolysis (GO:0051917) | 4.24626027 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.24180323 |
| 59 | DNA methylation involved in gamete generation (GO:0043046) | 4.23904275 |
| 60 | ketone body metabolic process (GO:1902224) | 4.22291354 |
| 61 | glutamate metabolic process (GO:0006536) | 4.21088435 |
| 62 | serine family amino acid metabolic process (GO:0009069) | 4.21042234 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.20895636 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 4.18147619 |
| 65 | benzene-containing compound metabolic process (GO:0042537) | 4.13573843 |
| 66 | aldehyde catabolic process (GO:0046185) | 4.12686712 |
| 67 | regulation of cholesterol esterification (GO:0010872) | 4.10072723 |
| 68 | 2-oxoglutarate metabolic process (GO:0006103) | 4.08370923 |
| 69 | drug transport (GO:0015893) | 4.05444115 |
| 70 | exogenous drug catabolic process (GO:0042738) | 4.03188242 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 4.02396983 |
| 72 | protein-lipid complex remodeling (GO:0034368) | 4.02396983 |
| 73 | macromolecular complex remodeling (GO:0034367) | 4.02396983 |
| 74 | aspartate family amino acid catabolic process (GO:0009068) | 4.01468967 |
| 75 | regulation of complement activation (GO:0030449) | 3.97649868 |
| 76 | reverse cholesterol transport (GO:0043691) | 3.95469162 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 3.93769508 |
| 78 | cellular glucuronidation (GO:0052695) | 3.93147979 |
| 79 | triglyceride homeostasis (GO:0070328) | 3.91850205 |
| 80 | acylglycerol homeostasis (GO:0055090) | 3.91850205 |
| 81 | ethanol oxidation (GO:0006069) | 3.91297932 |
| 82 | glycine metabolic process (GO:0006544) | 3.91252710 |
| 83 | organic acid catabolic process (GO:0016054) | 3.90507765 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.90507765 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 3.90470189 |
| 86 | negative regulation of sterol transport (GO:0032372) | 3.90470189 |
| 87 | fatty acid beta-oxidation (GO:0006635) | 3.90334783 |
| 88 | acetyl-CoA metabolic process (GO:0006084) | 3.85774592 |
| 89 | female gamete generation (GO:0007292) | 3.85048519 |
| 90 | bile acid and bile salt transport (GO:0015721) | 3.83497122 |
| 91 | flavonoid metabolic process (GO:0009812) | 3.83455968 |
| 92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.82580566 |
| 93 | fatty acid oxidation (GO:0019395) | 3.82369348 |
| 94 | valine metabolic process (GO:0006573) | 3.77758954 |
| 95 | lipid oxidation (GO:0034440) | 3.75413450 |
| 96 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.75003291 |
| 97 | monocarboxylic acid catabolic process (GO:0072329) | 3.74855438 |
| 98 | phospholipid efflux (GO:0033700) | 3.71814310 |
| 99 | fatty acid catabolic process (GO:0009062) | 3.70730799 |
| 100 | imidazole-containing compound metabolic process (GO:0052803) | 3.69959141 |
| 101 | carnitine metabolic process (GO:0009437) | 3.67866458 |
| 102 | regulation of female receptivity (GO:0045924) | 3.64527505 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.64288939 |
| 104 | uronic acid metabolic process (GO:0006063) | 3.64288939 |
| 105 | branched-chain amino acid catabolic process (GO:0009083) | 3.63838621 |
| 106 | arginine metabolic process (GO:0006525) | 3.63191305 |
| 107 | positive regulation of humoral immune response (GO:0002922) | 3.61868592 |
| 108 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.59680482 |
| 109 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.59680482 |
| 110 | aggressive behavior (GO:0002118) | 3.59467186 |
| 111 | NAD biosynthetic process (GO:0009435) | 3.58849509 |
| 112 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.58108414 |
| 113 | branched-chain amino acid metabolic process (GO:0009081) | 3.58089310 |
| 114 | cofactor catabolic process (GO:0051187) | 3.55931414 |
| 115 | female mating behavior (GO:0060180) | 3.53702104 |
| 116 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.52145261 |
| 117 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.52145261 |
| 118 | protein kinase C signaling (GO:0070528) | 3.51124498 |
| 119 | plasma lipoprotein particle clearance (GO:0034381) | 3.50674172 |
| 120 | low-density lipoprotein particle remodeling (GO:0034374) | 3.48567761 |
| 121 | regulation of steroid hormone secretion (GO:2000831) | 3.45200172 |
| 122 | drug metabolic process (GO:0017144) | 3.42393625 |
| 123 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.39995980 |
| 124 | sleep (GO:0030431) | 3.27294615 |
| 125 | neutrophil activation involved in immune response (GO:0002283) | 3.25644282 |
| 126 | regulation of cell maturation (GO:1903429) | 3.25433908 |
| 127 | neuron fate determination (GO:0048664) | 3.21553818 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 3.21498009 |
| 129 | phosphorelay signal transduction system (GO:0000160) | 3.20232758 |
| 130 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.19855679 |
| 131 | negative regulation of reproductive process (GO:2000242) | 3.15757996 |
| 132 | response to acidic pH (GO:0010447) | 3.15369221 |
| 133 | regulation of penile erection (GO:0060405) | 3.13517756 |
| 134 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.04311777 |
| 135 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.98803637 |
| 136 | oocyte development (GO:0048599) | 2.97939011 |
| 137 | amino acid import (GO:0043090) | 2.96661403 |
| 138 | reproduction (GO:0000003) | 2.94687200 |
| 139 | relaxation of smooth muscle (GO:0044557) | 2.86659000 |
| 140 | cellular response to pH (GO:0071467) | 2.86630609 |
| 141 | positive regulation of prostaglandin secretion (GO:0032308) | 2.84381533 |
| 142 | male meiosis I (GO:0007141) | 2.81945418 |
| 143 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.80619788 |
| 144 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.78848823 |
| 145 | organelle membrane fusion (GO:0090174) | 2.68100684 |
| 146 | positive regulation of reproductive process (GO:2000243) | 2.64865948 |
| 147 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.63654280 |
| 148 | positive regulation of mast cell degranulation (GO:0043306) | 2.63654280 |
| 149 | regulation of hypersensitivity (GO:0002883) | 2.60593031 |
| 150 | response to peptidoglycan (GO:0032494) | 2.60357056 |
| 151 | regulation of germinal center formation (GO:0002634) | 2.55385973 |
| 152 | cAMP catabolic process (GO:0006198) | 2.54142646 |
| 153 | positive regulation of isotype switching (GO:0045830) | 2.53992437 |
| 154 | positive regulation of gastrulation (GO:2000543) | 2.51941939 |
| 155 | positive regulation of DNA recombination (GO:0045911) | 2.51355936 |
| 156 | drinking behavior (GO:0042756) | 2.50503001 |
| 157 | lipoxygenase pathway (GO:0019372) | 2.46874047 |
| 158 | gene silencing by RNA (GO:0031047) | 2.40874192 |
| 159 | regulation of mast cell degranulation (GO:0043304) | 2.39771511 |
| 160 | positive regulation of digestive system process (GO:0060456) | 2.38311119 |
| 161 | positive regulation of mast cell activation (GO:0033005) | 2.38214573 |
| 162 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.38210171 |
| 163 | inositol phosphate catabolic process (GO:0071545) | 2.36829570 |
| 164 | maternal behavior (GO:0042711) | 2.35574473 |
| 165 | meiosis I (GO:0007127) | 2.35135790 |
| 166 | regulation of neuron projection regeneration (GO:0070570) | 2.33749640 |
| 167 | regulation of axon regeneration (GO:0048679) | 2.33749640 |
| 168 | regulation of histone H3-K9 methylation (GO:0051570) | 2.30498586 |
| 169 | oxidative demethylation (GO:0070989) | 2.29736811 |
| 170 | regulation of mast cell activation (GO:0033003) | 2.29405074 |
| 171 | oogenesis (GO:0048477) | 2.27938073 |
| 172 | positive regulation of fatty acid transport (GO:2000193) | 2.25991404 |
| 173 | autophagic vacuole fusion (GO:0000046) | 2.25048983 |
| 174 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.24182355 |
| 175 | positive regulation of icosanoid secretion (GO:0032305) | 2.23734384 |
| 176 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.23712891 |
| 177 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.23538531 |
| 178 | very long-chain fatty acid metabolic process (GO:0000038) | 2.23394487 |
| 179 | fertilization (GO:0009566) | 2.22312774 |
| 180 | macrophage activation involved in immune response (GO:0002281) | 2.21035866 |
| 181 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.20493052 |
| 182 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.19859114 |
| 183 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.19859114 |
| 184 | modulation by symbiont of host immune response (GO:0052553) | 2.19859114 |
| 185 | positive regulation by symbiont of host defense response (GO:0052509) | 2.19859114 |
| 186 | modulation by symbiont of host defense response (GO:0052031) | 2.19859114 |
| 187 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.19859114 |
| 188 | viral protein processing (GO:0019082) | 2.17812079 |
| 189 | dopamine biosynthetic process (GO:0042416) | 2.17379877 |
| 190 | cyclic nucleotide catabolic process (GO:0009214) | 2.17194307 |
| 191 | positive regulation of defense response to virus by host (GO:0002230) | 2.16935692 |
| 192 | male meiosis (GO:0007140) | 2.16727417 |
| 193 | positive regulation of antigen processing and presentation (GO:0002579) | 2.16214574 |
| 194 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.15857021 |
| 195 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.15826290 |
| 196 | single fertilization (GO:0007338) | 2.12562360 |
| 197 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.12474214 |
| 198 | positive regulation of steroid hormone secretion (GO:2000833) | 2.12376074 |
| 199 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.07761645 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.82838563 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.72327188 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.46280774 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.84081336 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.60557878 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91734907 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.78512836 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88648828 |
| 9 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.69620184 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.44122580 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14769606 |
| 12 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.73546476 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.61244444 |
| 14 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.30459920 |
| 15 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.22679509 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.09896698 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2166546 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 11.0344478 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91159219 |
| 20 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.82419897 |
| 21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78974411 |
| 22 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73766041 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.68474423 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.63196173 |
| 25 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.61521683 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.60968958 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58846065 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55709484 |
| 29 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.50523755 |
| 30 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.48673263 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47697352 |
| 32 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46839465 |
| 33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45276409 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43135394 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40276180 |
| 36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39053026 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36305614 |
| 38 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36254385 |
| 39 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34059377 |
| 40 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.30585403 |
| 41 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29444754 |
| 42 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23856421 |
| 43 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.23829199 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22316987 |
| 45 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20751785 |
| 46 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.19962566 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18952920 |
| 48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18747338 |
| 49 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18401658 |
| 50 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.14688654 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.13846531 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09649215 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09055067 |
| 54 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08467501 |
| 55 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08386244 |
| 56 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07989375 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07920117 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07106817 |
| 59 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.06074371 |
| 60 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.06074371 |
| 61 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.05593649 |
| 62 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03674560 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03674560 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03348277 |
| 65 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02052219 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.99273501 |
| 67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99259489 |
| 68 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99230109 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97468636 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97315417 |
| 71 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.97077465 |
| 72 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.97045709 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97017968 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96124912 |
| 75 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.95515068 |
| 76 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.95401869 |
| 77 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95376403 |
| 78 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95347145 |
| 79 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93439840 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 0.92162607 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92154980 |
| 82 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.91848039 |
| 83 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91734017 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91069352 |
| 85 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.90627779 |
| 86 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.89981134 |
| 87 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.89341727 |
| 88 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87029822 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86397264 |
| 90 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.85632839 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85342297 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84845012 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.84664131 |
| 94 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.84607420 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84383675 |
| 96 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83807664 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82325393 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 0.81901792 |
| 99 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.80755102 |
| 100 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.80239963 |
| 101 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.79862044 |
| 102 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.78611449 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78505036 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78330211 |
| 105 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.78238637 |
| 106 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78167617 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.78071223 |
| 108 | AR_20517297_ChIP-Seq_VCAP_Human | 0.77520052 |
| 109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.77220597 |
| 110 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.77193304 |
| 111 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.76999399 |
| 112 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.76328937 |
| 113 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76013707 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.75956137 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.74304237 |
| 116 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.71963987 |
| 117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71264370 |
| 118 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.71188672 |
| 119 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70483502 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70421845 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70091437 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69651261 |
| 123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.69494454 |
| 124 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.66717569 |
| 125 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.65615456 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65207383 |
| 127 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63996950 |
| 128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.63592984 |
| 129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63586410 |
| 130 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62866950 |
| 131 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.62302491 |
| 132 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.61643155 |
| 133 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.61589516 |
| 134 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.61207644 |
| 135 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.60988159 |
| 136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60961662 |
| 137 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.60515463 |
| 138 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.59735718 |
| 139 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.59735718 |
| 140 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.59104753 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.58961842 |
| 142 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.58507906 |
| 143 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.57823064 |
| 144 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57142543 |
| 145 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.56968360 |
| 146 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.56276366 |
| 147 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.55916907 |
| 148 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.54956416 |
| 149 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53779231 |
| 150 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.53284909 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52831739 |
| 152 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.52123553 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52068332 |
| 154 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51473369 |
| 155 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.51226307 |
| 156 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.51169809 |
| 157 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48859980 |
| 158 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48530855 |
| 159 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.48351671 |
| 160 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.47943529 |
| 161 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.47676731 |
| 162 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.47568628 |
| 163 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.47220701 |
| 164 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.46796212 |
| 165 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.46479950 |
| 166 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.46288148 |
| 167 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46243106 |
| 168 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.46242442 |
| 169 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46172127 |
| 170 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.46004104 |
| 171 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44457096 |
| 172 | CBP_21632823_ChIP-Seq_H3396_Human | 0.44205219 |
| 173 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44045009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.71338103 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.65528930 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.75738686 |
| 4 | MP0005365_abnormal_bile_salt | 5.60769340 |
| 5 | MP0003718_maternal_effect | 5.25950625 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.00973004 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.69249986 |
| 8 | MP0003252_abnormal_bile_duct | 3.47011392 |
| 9 | MP0005332_abnormal_amino_acid | 3.30339321 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.24157337 |
| 11 | MP0003195_calcinosis | 3.09815942 |
| 12 | MP0009840_abnormal_foam_cell | 2.66104386 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.56812124 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.52800391 |
| 15 | MP0005083_abnormal_biliary_tract | 2.44680997 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.42758152 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.37892774 |
| 18 | MP0008789_abnormal_olfactory_epithelium | 2.24225247 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 2.19538388 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.10260708 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.07427486 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.06001056 |
| 23 | MP0001764_abnormal_homeostasis | 2.01277183 |
| 24 | MP0003303_peritoneal_inflammation | 1.97376219 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 1.95664096 |
| 26 | MP0005499_abnormal_olfactory_system | 1.93283631 |
| 27 | MP0005394_taste/olfaction_phenotype | 1.93283631 |
| 28 | MP0000609_abnormal_liver_physiology | 1.91569458 |
| 29 | * MP0005319_abnormal_enzyme/_coenzyme | 1.89797441 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.87514566 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.82842886 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.82672188 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.80649433 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.79124072 |
| 35 | MP0002272_abnormal_nervous_system | 1.65914059 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.63664091 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.55865180 |
| 38 | MP0003868_abnormal_feces_composition | 1.53682862 |
| 39 | * MP0003186_abnormal_redox_activity | 1.51694124 |
| 40 | MP0002736_abnormal_nociception_after | 1.50939382 |
| 41 | MP0006292_abnormal_olfactory_placode | 1.46677248 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.46205276 |
| 43 | MP0005410_abnormal_fertilization | 1.41872301 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.41324180 |
| 45 | MP0002234_abnormal_pharynx_morphology | 1.34801356 |
| 46 | MP0009697_abnormal_copulation | 1.33994038 |
| 47 | MP0004270_analgesia | 1.32898977 |
| 48 | MP0005451_abnormal_body_composition | 1.31609252 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.27943077 |
| 50 | MP0009745_abnormal_behavioral_response | 1.26231759 |
| 51 | MP0009764_decreased_sensitivity_to | 1.23093326 |
| 52 | MP0003635_abnormal_synaptic_transmissio | 1.22913684 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.22790222 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.20676116 |
| 55 | MP0004142_abnormal_muscle_tone | 1.19107184 |
| 56 | MP0004043_abnormal_pH_regulation | 1.17663325 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.13937253 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.12178988 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.12178988 |
| 60 | MP0002064_seizures | 1.11807049 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.11632506 |
| 62 | MP0001790_abnormal_immune_system | 1.11130483 |
| 63 | MP0005387_immune_system_phenotype | 1.11130483 |
| 64 | MP0008469_abnormal_protein_level | 1.10468534 |
| 65 | MP0002723_abnormal_immune_serum | 1.10361699 |
| 66 | MP0003011_delayed_dark_adaptation | 1.09513755 |
| 67 | MP0003699_abnormal_female_reproductive | 1.09039838 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 1.08462252 |
| 69 | MP0004859_abnormal_synaptic_plasticity | 1.07753389 |
| 70 | MP0005535_abnormal_body_temperature | 1.07651423 |
| 71 | MP0005646_abnormal_pituitary_gland | 1.07643170 |
| 72 | MP0000598_abnormal_liver_morphology | 1.06246850 |
| 73 | MP0000604_amyloidosis | 1.05107208 |
| 74 | MP0001486_abnormal_startle_reflex | 1.04163700 |
| 75 | MP0003724_increased_susceptibility_to | 1.02467126 |
| 76 | MP0001765_abnormal_ion_homeostasis | 1.02360649 |
| 77 | MP0002452_abnormal_antigen_presenting | 1.01120073 |
| 78 | MP0001984_abnormal_olfaction | 1.00436563 |
| 79 | MP0001800_abnormal_humoral_immune | 0.99928321 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.98136319 |
| 81 | MP0002653_abnormal_ependyma_morphology | 0.97925935 |
| 82 | MP0009763_increased_sensitivity_to | 0.97747073 |
| 83 | MP0002420_abnormal_adaptive_immunity | 0.97458785 |
| 84 | MP0001756_abnormal_urination | 0.97000497 |
| 85 | MP0005670_abnormal_white_adipose | 0.96516115 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 0.95733737 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.95489316 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.93842543 |
| 89 | MP0001819_abnormal_immune_cell | 0.93352524 |
| 90 | MP0002067_abnormal_sensory_capabilities | 0.92933261 |
| 91 | MP0003880_abnormal_central_pattern | 0.92171545 |
| 92 | MP0001929_abnormal_gametogenesis | 0.91978652 |
| 93 | MP0002063_abnormal_learning/memory/cond | 0.91522507 |
| 94 | MP0005647_abnormal_sex_gland | 0.90888677 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.90009735 |
| 96 | MP0003633_abnormal_nervous_system | 0.89966330 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.87928978 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.87283450 |
| 99 | MP0002572_abnormal_emotion/affect_behav | 0.87223979 |
| 100 | MP0000343_altered_response_to | 0.83729639 |
| 101 | MP0001664_abnormal_digestion | 0.82600775 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.79904444 |
| 103 | MP0003436_decreased_susceptibility_to | 0.79442840 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.79366162 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.79154038 |
| 106 | MP0003950_abnormal_plasma_membrane | 0.78178200 |
| 107 | MP0003329_amyloid_beta_deposits | 0.77384426 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 0.76735879 |
| 109 | MP0004742_abnormal_vestibular_system | 0.76668908 |
| 110 | MP0004130_abnormal_muscle_cell | 0.76597677 |
| 111 | MP0001533_abnormal_skeleton_physiology | 0.75717983 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.75549438 |
| 113 | MP0003136_yellow_coat_color | 0.74198567 |
| 114 | MP0001970_abnormal_pain_threshold | 0.73671763 |
| 115 | MP0004510_myositis | 0.73546882 |
| 116 | MP0003638_abnormal_response/metabolism_ | 0.73052820 |
| 117 | MP0009785_altered_susceptibility_to | 0.71444810 |
| 118 | MP0004147_increased_porphyrin_level | 0.71147499 |
| 119 | MP0002822_catalepsy | 0.70376551 |
| 120 | MP0002971_abnormal_brown_adipose | 0.69749424 |
| 121 | MP0005266_abnormal_metabolism | 0.69688826 |
| 122 | MP0005334_abnormal_fat_pad | 0.65578729 |
| 123 | MP0003075_altered_response_to | 0.65318113 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.65223287 |
| 125 | MP0001853_heart_inflammation | 0.64714761 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.64131646 |
| 127 | MP0008874_decreased_physiological_sensi | 0.62272469 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.61929583 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.61912176 |
| 130 | MP0008872_abnormal_physiological_respon | 0.58837012 |
| 131 | MP0005166_decreased_susceptibility_to | 0.58570838 |
| 132 | MP0005448_abnormal_energy_balance | 0.57047930 |
| 133 | MP0003646_muscle_fatigue | 0.56878894 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.54467888 |
| 135 | MP0004782_abnormal_surfactant_physiolog | 0.53908305 |
| 136 | MP0009379_abnormal_foot_pigmentation | 0.53532562 |
| 137 | MP0002254_reproductive_system_inflammat | 0.53266664 |
| 138 | MP0003690_abnormal_glial_cell | 0.51515042 |
| 139 | MP0010368_abnormal_lymphatic_system | 0.51096518 |
| 140 | MP0008873_increased_physiological_sensi | 0.49697227 |
| 141 | MP0003953_abnormal_hormone_level | 0.49566539 |
| 142 | MP0005025_abnormal_response_to | 0.48290625 |
| 143 | MP0001661_extended_life_span | 0.46021347 |
| 144 | MP0005408_hypopigmentation | 0.45166691 |
| 145 | MP0002928_abnormal_bile_duct | 0.44979504 |
| 146 | MP0000538_abnormal_urinary_bladder | 0.44883959 |
| 147 | MP0002419_abnormal_innate_immunity | 0.44705452 |
| 148 | MP0001835_abnormal_antigen_presentation | 0.44419430 |
| 149 | MP0001663_abnormal_digestive_system | 0.42239140 |
| 150 | MP0005165_increased_susceptibility_to | 0.40999325 |
| 151 | MP0005666_abnormal_adipose_tissue | 0.40814926 |
| 152 | MP0002135_abnormal_kidney_morphology | 0.34786792 |
| 153 | MP0003879_abnormal_hair_cell | 0.32941440 |
| 154 | MP0005595_abnormal_vascular_smooth | 0.31949595 |
| 155 | MP0006082_CNS_inflammation | 0.31869040 |
| 156 | MP0009115_abnormal_fat_cell | 0.30055938 |
| 157 | MP0003959_abnormal_lean_body | 0.29913931 |
| 158 | MP0000639_abnormal_adrenal_gland | 0.29731950 |
| 159 | MP0005395_other_phenotype | 0.29702390 |
| 160 | MP0000249_abnormal_blood_vessel | 0.28317950 |
| 161 | MP0008961_abnormal_basal_metabolism | 0.27906472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.43328953 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.68865832 |
| 3 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 5.37456775 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.35470064 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.34950438 |
| 6 | Xanthomatosis (HP:0000991) | 5.07858084 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.00141078 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.96648086 |
| 9 | Hyperammonemia (HP:0001987) | 4.62679451 |
| 10 | Ketosis (HP:0001946) | 4.52927918 |
| 11 | Hyperglycinuria (HP:0003108) | 4.47204413 |
| 12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.45030261 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.44587207 |
| 14 | Hyperglycinemia (HP:0002154) | 4.26269946 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.23694925 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.23694925 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.00604606 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97355763 |
| 19 | Joint hemorrhage (HP:0005261) | 3.91729105 |
| 20 | Complement deficiency (HP:0004431) | 3.91727074 |
| 21 | Gout (HP:0001997) | 3.70722654 |
| 22 | Loss of speech (HP:0002371) | 3.70568997 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70203149 |
| 24 | Ketoacidosis (HP:0001993) | 3.67808199 |
| 25 | Hypolipoproteinemia (HP:0010981) | 3.54958124 |
| 26 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.49814867 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.46464872 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.46464872 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.46464872 |
| 30 | Hypoglycemic coma (HP:0001325) | 3.43593272 |
| 31 | Fat malabsorption (HP:0002630) | 3.42409233 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.41417165 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 3.40091009 |
| 34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.39350031 |
| 35 | Abnormality of nucleobase metabolism (HP:0010932) | 3.37786422 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 3.35971050 |
| 37 | Metabolic acidosis (HP:0001942) | 3.34900134 |
| 38 | Mutism (HP:0002300) | 3.34705049 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.30777527 |
| 40 | Epidermoid cyst (HP:0200040) | 3.28945936 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.28307402 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 3.28307402 |
| 43 | Delayed CNS myelination (HP:0002188) | 3.23921284 |
| 44 | Generalized aminoaciduria (HP:0002909) | 3.22940815 |
| 45 | Diminished motivation (HP:0000745) | 3.21125954 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.17835481 |
| 47 | Hypophosphatemic rickets (HP:0004912) | 3.15791541 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 3.12458062 |
| 49 | Apathy (HP:0000741) | 3.11858787 |
| 50 | Male infertility (HP:0003251) | 3.11779017 |
| 51 | Lethargy (HP:0001254) | 3.10172822 |
| 52 | Hyperbilirubinemia (HP:0002904) | 3.07836127 |
| 53 | Stomatitis (HP:0010280) | 3.02974880 |
| 54 | Cerebral edema (HP:0002181) | 3.00680094 |
| 55 | Congenital sensorineural hearing impairment (HP:0008527) | 2.96316536 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.94756807 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.93683908 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.90059144 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.90013720 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.82686845 |
| 61 | Hypercholesterolemia (HP:0003124) | 2.80455602 |
| 62 | Myositis (HP:0100614) | 2.80209411 |
| 63 | Myokymia (HP:0002411) | 2.78811164 |
| 64 | Abnormality of complement system (HP:0005339) | 2.77965805 |
| 65 | Abnormality of the intrinsic pathway (HP:0010989) | 2.77206579 |
| 66 | Alkalosis (HP:0001948) | 2.74093432 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.72925503 |
| 68 | Glycosuria (HP:0003076) | 2.72925503 |
| 69 | Vomiting (HP:0002013) | 2.66751979 |
| 70 | Hyperuricemia (HP:0002149) | 2.65769691 |
| 71 | Increased purine levels (HP:0004368) | 2.65769691 |
| 72 | Conjunctival telangiectasia (HP:0000524) | 2.64018323 |
| 73 | Steatorrhea (HP:0002570) | 2.62626817 |
| 74 | Supernumerary spleens (HP:0009799) | 2.61378236 |
| 75 | Septo-optic dysplasia (HP:0100842) | 2.59573549 |
| 76 | Hypokinesia (HP:0002375) | 2.59484125 |
| 77 | Prolonged neonatal jaundice (HP:0006579) | 2.53419570 |
| 78 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.49866119 |
| 79 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.48967817 |
| 80 | Hypoplasia of the fovea (HP:0007750) | 2.48967817 |
| 81 | Osteomalacia (HP:0002749) | 2.45792893 |
| 82 | Anterior segment dysgenesis (HP:0007700) | 2.44929927 |
| 83 | Hepatic necrosis (HP:0002605) | 2.42741918 |
| 84 | Hepatocellular carcinoma (HP:0001402) | 2.39401478 |
| 85 | Vascular calcification (HP:0004934) | 2.36932493 |
| 86 | Neonatal onset (HP:0003623) | 2.35717852 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35509716 |
| 88 | Spontaneous abortion (HP:0005268) | 2.33664963 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.33484920 |
| 90 | Late onset (HP:0003584) | 2.33225651 |
| 91 | Orchitis (HP:0100796) | 2.32946052 |
| 92 | Irritability (HP:0000737) | 2.31604503 |
| 93 | Acute encephalopathy (HP:0006846) | 2.29933243 |
| 94 | Malnutrition (HP:0004395) | 2.26941968 |
| 95 | Spastic diplegia (HP:0001264) | 2.25353069 |
| 96 | Dysostosis multiplex (HP:0000943) | 2.23985283 |
| 97 | Pancreatitis (HP:0001733) | 2.22714260 |
| 98 | Action tremor (HP:0002345) | 2.22501698 |
| 99 | Nausea (HP:0002018) | 2.21675607 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.21592952 |
| 101 | Metaphyseal irregularity (HP:0003025) | 2.21197408 |
| 102 | Albinism (HP:0001022) | 2.19553380 |
| 103 | Bundle branch block (HP:0011710) | 2.18165553 |
| 104 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.15768364 |
| 105 | Hyperactive renin-angiotensin system (HP:0000841) | 2.13775022 |
| 106 | Increased muscle lipid content (HP:0009058) | 2.13569632 |
| 107 | Focal motor seizures (HP:0011153) | 2.13348348 |
| 108 | Optic neuritis (HP:0100653) | 2.12176171 |
| 109 | Retrobulbar optic neuritis (HP:0100654) | 2.12176171 |
| 110 | Hydroxyprolinuria (HP:0003080) | 2.11762149 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 2.11762149 |
| 112 | Hyperphosphaturia (HP:0003109) | 2.11328353 |
| 113 | Infertility (HP:0000789) | 2.09273526 |
| 114 | Skin nodule (HP:0200036) | 2.08188681 |
| 115 | Hyperventilation (HP:0002883) | 2.07174995 |
| 116 | Delusions (HP:0000746) | 2.05426690 |
| 117 | Abnormal ciliary motility (HP:0012262) | 2.03710449 |
| 118 | Brushfield spots (HP:0001088) | 2.03461649 |
| 119 | Azoospermia (HP:0000027) | 2.03152616 |
| 120 | Anhidrosis (HP:0000970) | 2.01517610 |
| 121 | Abnormality of the fovea (HP:0000493) | 2.00839669 |
| 122 | Cardiovascular calcification (HP:0011915) | 2.00718519 |
| 123 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.00088740 |
| 124 | Fair hair (HP:0002286) | 1.99564520 |
| 125 | Neurofibrillary tangles (HP:0002185) | 1.99503994 |
| 126 | Cholecystitis (HP:0001082) | 1.99297394 |
| 127 | Abnormal gallbladder physiology (HP:0012438) | 1.99297394 |
| 128 | Abnormal biliary tract physiology (HP:0012439) | 1.98929762 |
| 129 | Bile duct proliferation (HP:0001408) | 1.98929762 |
| 130 | Increased cerebral lipofuscin (HP:0011813) | 1.98900249 |
| 131 | Enlarged kidneys (HP:0000105) | 1.98448382 |
| 132 | Opisthotonus (HP:0002179) | 1.97888446 |
| 133 | Methylmalonic aciduria (HP:0012120) | 1.96664530 |
| 134 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.96312448 |
| 135 | Absent/shortened dynein arms (HP:0200106) | 1.96312448 |
| 136 | Cholelithiasis (HP:0001081) | 1.95973676 |
| 137 | Lactic acidosis (HP:0003128) | 1.94237223 |
| 138 | Abnormal gallbladder morphology (HP:0012437) | 1.93984338 |
| 139 | Vacuolated lymphocytes (HP:0001922) | 1.93756675 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.92420896 |
| 141 | Papillary thyroid carcinoma (HP:0002895) | 1.90712867 |
| 142 | Thrombophlebitis (HP:0004418) | 1.90529172 |
| 143 | Increased circulating renin level (HP:0000848) | 1.90452197 |
| 144 | Menorrhagia (HP:0000132) | 1.90288158 |
| 145 | Renal cortical cysts (HP:0000803) | 1.89935309 |
| 146 | Rickets (HP:0002748) | 1.89308874 |
| 147 | Hepatocellular necrosis (HP:0001404) | 1.88960999 |
| 148 | Acanthocytosis (HP:0001927) | 1.88209809 |
| 149 | Elevated hepatic transaminases (HP:0002910) | 1.87706698 |
| 150 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86469936 |
| 151 | Metaphyseal dysplasia (HP:0100255) | 1.86176682 |
| 152 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85844588 |
| 153 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85844588 |
| 154 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85844588 |
| 155 | Absent speech (HP:0001344) | 1.85215708 |
| 156 | Memory impairment (HP:0002354) | 1.85086762 |
| 157 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84959272 |
| 158 | Myocardial infarction (HP:0001658) | 1.84353971 |
| 159 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84304948 |
| 160 | Tubulointerstitial nephritis (HP:0001970) | 1.84203976 |
| 161 | Amyloidosis (HP:0011034) | 1.84031114 |
| 162 | Impulsivity (HP:0100710) | 1.83727801 |
| 163 | Progressive neurologic deterioration (HP:0002344) | 1.82719602 |
| 164 | Median cleft lip (HP:0000161) | 1.81775738 |
| 165 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.81558464 |
| 166 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.81077026 |
| 167 | Nephrolithiasis (HP:0000787) | 1.80376501 |
| 168 | Dementia (HP:0000726) | 1.80156623 |
| 169 | Petechiae (HP:0000967) | 1.80057679 |
| 170 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79639827 |
| 171 | Obstructive lung disease (HP:0006536) | 1.79639827 |
| 172 | Premature ovarian failure (HP:0008209) | 1.76982263 |
| 173 | Abnormality of midbrain morphology (HP:0002418) | 1.75757806 |
| 174 | Molar tooth sign on MRI (HP:0002419) | 1.75757806 |
| 175 | Episodic fever (HP:0001954) | 1.75730714 |
| 176 | Supranuclear gaze palsy (HP:0000605) | 1.71911136 |
| 177 | Prostate neoplasm (HP:0100787) | 1.71818021 |
| 178 | Neuronal loss in central nervous system (HP:0002529) | 1.71814772 |
| 179 | Dysdiadochokinesis (HP:0002075) | 1.71147109 |
| 180 | Short tibia (HP:0005736) | 1.70732100 |
| 181 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.69290346 |
| 182 | Severe visual impairment (HP:0001141) | 1.68492368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.25736025 |
| 2 | ARAF | 4.93258643 |
| 3 | ERN1 | 3.89407405 |
| 4 | MAP3K9 | 3.22109971 |
| 5 | FGFR4 | 3.04025232 |
| 6 | MOS | 2.54296115 |
| 7 | OXSR1 | 2.36332287 |
| 8 | SIK1 | 2.28854963 |
| 9 | TAOK3 | 2.26139348 |
| 10 | WNK3 | 2.23233966 |
| 11 | GRK6 | 2.21718857 |
| 12 | MAP2K4 | 2.15321587 |
| 13 | WNK4 | 2.14791542 |
| 14 | MAP3K12 | 1.90278827 |
| 15 | EPHA4 | 1.88295982 |
| 16 | BRAF | 1.78712847 |
| 17 | FLT3 | 1.77455639 |
| 18 | INSRR | 1.76663966 |
| 19 | MST1R | 1.72674311 |
| 20 | RAF1 | 1.70224772 |
| 21 | NTRK2 | 1.69634161 |
| 22 | NUAK1 | 1.67168626 |
| 23 | MAPK13 | 1.66860402 |
| 24 | IRAK1 | 1.59520152 |
| 25 | IRAK2 | 1.57074499 |
| 26 | ERBB4 | 1.56272651 |
| 27 | TNK2 | 1.53393843 |
| 28 | ABL2 | 1.52726007 |
| 29 | MYLK | 1.51919179 |
| 30 | MAPK11 | 1.51095760 |
| 31 | KSR2 | 1.50472497 |
| 32 | MAP2K3 | 1.46775073 |
| 33 | MAP3K11 | 1.45463095 |
| 34 | PINK1 | 1.45359498 |
| 35 | PDK3 | 1.42913749 |
| 36 | PDK4 | 1.42913749 |
| 37 | STK16 | 1.41719311 |
| 38 | KDR | 1.37547874 |
| 39 | DAPK1 | 1.33955673 |
| 40 | MAP3K14 | 1.33752305 |
| 41 | PIK3CG | 1.33661516 |
| 42 | TBK1 | 1.31997054 |
| 43 | TAOK1 | 1.29512020 |
| 44 | MAP2K6 | 1.28994222 |
| 45 | DAPK2 | 1.28797605 |
| 46 | RIPK4 | 1.26619220 |
| 47 | KIT | 1.26383299 |
| 48 | TYK2 | 1.26146589 |
| 49 | NEK6 | 1.22591188 |
| 50 | PKN2 | 1.14445367 |
| 51 | MAP3K7 | 1.12682035 |
| 52 | TIE1 | 1.12199209 |
| 53 | NTRK3 | 1.11308776 |
| 54 | MARK3 | 1.11214942 |
| 55 | MAPK4 | 1.10768955 |
| 56 | PRKAA2 | 1.10664690 |
| 57 | IKBKB | 1.10382693 |
| 58 | GRK5 | 1.07652589 |
| 59 | EIF2AK1 | 1.05247048 |
| 60 | MAP4K1 | 1.04210095 |
| 61 | NEK1 | 1.02955451 |
| 62 | CSF1R | 1.01500138 |
| 63 | MARK1 | 1.00792826 |
| 64 | ADRBK2 | 0.99627385 |
| 65 | PIM2 | 0.98657224 |
| 66 | SYK | 0.95367579 |
| 67 | PKN1 | 0.94718387 |
| 68 | CAMKK2 | 0.94709552 |
| 69 | TESK2 | 0.94462241 |
| 70 | MAPK7 | 0.93615381 |
| 71 | BTK | 0.93030340 |
| 72 | MAP2K7 | 0.91882935 |
| 73 | MAPK12 | 0.91613973 |
| 74 | CDK9 | 0.90145372 |
| 75 | TRIB3 | 0.89575311 |
| 76 | NME2 | 0.88397327 |
| 77 | MUSK | 0.87120583 |
| 78 | MAP3K6 | 0.86911805 |
| 79 | NEK9 | 0.86133249 |
| 80 | AURKA | 0.86049653 |
| 81 | JAK2 | 0.85797832 |
| 82 | CDK19 | 0.85366253 |
| 83 | TEC | 0.82923503 |
| 84 | TXK | 0.82139736 |
| 85 | CSNK1G3 | 0.80927676 |
| 86 | BLK | 0.80238841 |
| 87 | TAOK2 | 0.79514196 |
| 88 | STK24 | 0.79018406 |
| 89 | PIM1 | 0.77506766 |
| 90 | IRAK4 | 0.77504445 |
| 91 | PRKCI | 0.77467285 |
| 92 | IKBKE | 0.71772476 |
| 93 | MAP3K5 | 0.71566593 |
| 94 | ACVR1B | 0.71326251 |
| 95 | CSNK1G2 | 0.70024393 |
| 96 | CSNK1G1 | 0.69503813 |
| 97 | KSR1 | 0.69092667 |
| 98 | PRKACG | 0.68138835 |
| 99 | SGK2 | 0.67190685 |
| 100 | TLK1 | 0.66799624 |
| 101 | MAP3K3 | 0.66035284 |
| 102 | PRKG1 | 0.65051375 |
| 103 | TGFBR2 | 0.64081273 |
| 104 | SIK3 | 0.63692586 |
| 105 | CDK5 | 0.61143779 |
| 106 | PRKCZ | 0.59799240 |
| 107 | EIF2AK3 | 0.59701784 |
| 108 | IRAK3 | 0.59311847 |
| 109 | SGK494 | 0.59086272 |
| 110 | SGK223 | 0.59086272 |
| 111 | JAK1 | 0.58556742 |
| 112 | VRK1 | 0.57986699 |
| 113 | ZAP70 | 0.57708686 |
| 114 | PRKCG | 0.54104069 |
| 115 | CAMK2A | 0.53399789 |
| 116 | PDK2 | 0.53325453 |
| 117 | TESK1 | 0.51788177 |
| 118 | CSNK1A1L | 0.51781895 |
| 119 | LYN | 0.51429211 |
| 120 | PRKCQ | 0.51250728 |
| 121 | PRKAA1 | 0.49935973 |
| 122 | MATK | 0.48761698 |
| 123 | BMPR2 | 0.48222117 |
| 124 | CAMK2G | 0.47511353 |
| 125 | PDPK1 | 0.47071700 |
| 126 | PRKCD | 0.46641302 |
| 127 | SGK3 | 0.46194768 |
| 128 | FRK | 0.44796454 |
| 129 | GSK3A | 0.44786452 |
| 130 | PDK1 | 0.44514290 |
| 131 | CCNB1 | 0.44082135 |
| 132 | TNIK | 0.43965785 |
| 133 | PRPF4B | 0.42659556 |
| 134 | FES | 0.42115289 |
| 135 | PRKD3 | 0.42003850 |
| 136 | CASK | 0.40613499 |
| 137 | PTK2B | 0.40128406 |
| 138 | DMPK | 0.39763653 |
| 139 | PRKG2 | 0.39293396 |
| 140 | MAP3K13 | 0.38568678 |
| 141 | STK38L | 0.38281483 |
| 142 | GRK7 | 0.38139221 |
| 143 | LIMK1 | 0.38134298 |
| 144 | PRKCA | 0.36846309 |
| 145 | CAMK4 | 0.32264151 |
| 146 | IGF1R | 0.31606519 |
| 147 | MAP3K4 | 0.31388424 |
| 148 | CSK | 0.30769892 |
| 149 | MAP3K1 | 0.30628227 |
| 150 | PRKACA | 0.29851882 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.00381088 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39945143 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25072385 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.85974595 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74900250 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72830851 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.68502055 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66432138 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64834657 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52200361 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51087097 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.49044146 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.40538893 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.40117728 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.35184327 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.17338544 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.09728306 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.09713655 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 2.00597938 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97191985 |
| 21 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.92274340 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.88358326 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88310775 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86196189 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80627008 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.79438124 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78514079 |
| 28 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.78453472 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78295746 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77766375 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.74403032 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73173640 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.70275614 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67415697 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65697240 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.65054603 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60502242 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58192961 |
| 39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57114454 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56749773 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56089750 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.51869951 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48928295 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47889007 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.46336081 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45989271 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44358465 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.43282435 |
| 49 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.42931794 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.42163999 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41981705 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41411897 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38539905 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37279116 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34334015 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34039882 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33493938 |
| 58 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32735193 |
| 59 | GABAergic synapse_Homo sapiens_hsa04727 | 1.32186830 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28940469 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26303858 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24357136 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.23596869 |
| 64 | Olfactory transduction_Homo sapiens_hsa04740 | 1.23078319 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.18718029 |
| 66 | Lysosome_Homo sapiens_hsa04142 | 1.15970591 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 1.13697358 |
| 68 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.12598336 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 1.12093345 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09522548 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 1.09016180 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 1.04261932 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03717731 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03686225 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.02264260 |
| 76 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01189035 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00783325 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 1.00608665 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96592186 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96396084 |
| 81 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95667858 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95004039 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.94675923 |
| 84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.93854484 |
| 85 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.90949557 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.89887401 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89053494 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88397657 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.87858717 |
| 90 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86591554 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.86373110 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.79943523 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77970220 |
| 94 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77885248 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77711460 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.77111960 |
| 97 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76670045 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76357125 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74417803 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74135318 |
| 101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74113630 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73921148 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.68158447 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.67766882 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67473347 |
| 106 | Lysine degradation_Homo sapiens_hsa00310 | 0.66369748 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66106745 |
| 108 | Salivary secretion_Homo sapiens_hsa04970 | 0.65402699 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64696394 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64479143 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64417699 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64126570 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.61942445 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61270547 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60940544 |
| 116 | Metabolic pathways_Homo sapiens_hsa01100 | 0.60677845 |
| 117 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60495246 |
| 118 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56797424 |
| 119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56489244 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55006415 |
| 121 | Malaria_Homo sapiens_hsa05144 | 0.53505501 |
| 122 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.53238745 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51086889 |
| 124 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50249317 |
| 125 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49692522 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49219593 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.48114528 |
| 128 | Renin secretion_Homo sapiens_hsa04924 | 0.47843613 |
| 129 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47368683 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45714890 |
| 131 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44705720 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44595200 |
| 133 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.39533653 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38015153 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35415886 |
| 136 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32384320 |
| 137 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22615552 |
| 138 | Alzheimers disease_Homo sapiens_hsa05010 | 0.20966412 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13532711 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.08803216 |
| 141 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.06036773 |
| 142 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04055096 |
| 143 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.03848742 |
| 144 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03331320 |
| 145 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.03304491 |
| 146 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01280755 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.00732391 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1936509 |
| 149 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1623405 |
| 150 | Mineral absorption_Homo sapiens_hsa04978 | -0.1461528 |
| 151 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1449360 |
| 152 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1326993 |
| 153 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1181987 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1098253 |
| 155 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1096859 |
| 156 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1033565 |
| 157 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0931838 |
| 158 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0660920 |
| 159 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0502723 |
| 160 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0436167 |
| 161 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0393931 |
| 162 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0288427 |
| 163 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0273027 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0080450 |

